Loomis, Sayles & Company’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $3.59M | Buy |
+15,105
| New | +$3.14M | ﹤0.01% | 456 |
|
|
2025
Q4 | – | Sell |
-15,924
| Closed | -$2.5M | – | 709 |
|
|
2025
Q3 | $2.5M | Hold |
15,924
| – | – | ﹤0.01% | 453 |
|
|
2025
Q2 | $2.68M | Buy |
15,924
+9,690
| +155% | +$1.44M | ﹤0.01% | 448 |
|
|
2025
Q1 | $859K | Sell |
6,234
-6
| -0.1% | -$765 | ﹤0.01% | 475 |
|
|
2024
Q4 | $738K | Sell |
6,240
-596
| -9% | -$69.6K | ﹤0.01% | 480 |
|
|
2024
Q3 | $756K | Buy |
6,836
+5,925
| +650% | +$619K | ﹤0.01% | 464 |
|
|
2024
Q2 | $90K | Hold |
911
| – | – | ﹤0.01% | 553 |
|
|
2024
Q1 | $102K | Buy |
911
+657
| +259% | +$70.9K | ﹤0.01% | 541 |
|
|
2023
Q4 | $26K | Buy |
254
+85
| +50% | +$8.43K | ﹤0.01% | 668 |
|
|
2023
Q3 | $15K | Sell |
169
-22
| -12% | -$1.99K | ﹤0.01% | 715 |
|
|
2023
Q2 | $18K | Sell |
191
-365
| -66% | -$30.8K | ﹤0.01% | 695 |
|
|
2023
Q1 | $42K | Buy |
556
+349
| +169% | +$26.3K | ﹤0.01% | 645 |
|
|
2022
Q4 | $16K | Buy |
+207
| New | +$15.7K | ﹤0.01% | 742 |
|
|
2022
Q3 | – | Sell |
-195
| Closed | -$10K | – | 961 |
|
|
2022
Q2 | $10K | Sell |
195
-138
| -41% | -$7.84K | ﹤0.01% | 659 |
|
|
2022
Q1 | $19K | Buy |
+333
| New | +$17.8K | ﹤0.01% | 637 |
|
|
2021
Q4 | – | Sell |
-155
| Closed | -$8K | – | 788 |
|
|
2021
Q3 | $8K | Hold |
155
| – | – | ﹤0.01% | 862 |
|
|
2021
Q2 | $9K | Buy |
+155
| New | +$9.06K | ﹤0.01% | 793 |
|
|
2020
Q3 | – | Sell |
-279
| Closed | -$15K | – | 663 |
|
|
2020
Q2 | $15K | Sell |
279
-15
| -5% | -$773 | ﹤0.01% | 603 |
|
|
2020
Q1 | $14K | Buy |
+294
| New | +$15.3K | ﹤0.01% | 612 |
|
|
2019
Q2 | – | Sell |
-230
| Closed | -$11K | – | 591 |
|
|
2019
Q1 | $11K | Buy |
+230
| New | +$11.5K | ﹤0.01% | 712 |
|
|
2016
Q2 | – | Sell |
-1,090
| Closed | -$89K | – | 1019 |
|
|
2016
Q1 | $89K | Buy |
1,090
+5
| +0.5% | +$407 | ﹤0.01% | 675 |
|
|
2015
Q4 | $97K | Sell |
1,085
-193
| -15% | -$16.4K | ﹤0.01% | 713 |
|
|
2015
Q3 | $98K | Buy |
+1,278
| New | +$107K | ﹤0.01% | 748 |
|
|
2015
Q1 | – | Sell |
-2,378
| Closed | -$192K | – | 733 |
|
|
2014
Q4 | $192K | Buy |
2,378
+24
| +1% | +$1.9K | ﹤0.01% | 637 |
|
|
2014
Q3 | $176K | Buy |
2,354
+33
| +1% | +$2.4K | ﹤0.01% | 635 |
|
|
2014
Q2 | $159K | Hold |
2,321
| – | – | ﹤0.01% | 662 |
|
|
2014
Q1 | $162K | Sell |
2,321
-2,813
| -55% | -$196K | ﹤0.01% | 642 |
|
|
2013
Q4 | $343K | Sell |
5,134
-2,136
| -29% | -$131K | ﹤0.01% | 655 |
|
|
2013
Q3 | $379K | Sell |
7,270
-335
| -4% | -$17K | ﹤0.01% | 642 |
|
|
2013
Q2 | $359K | Buy |
+7,605
| New | +$347K | ﹤0.01% | 635 |
|
Other funds holding CAH
Loomis, Sayles & Company's CAH Position: Q2 2026 in Review
Loomis, Sayles & Company opened a new position in Cardinal Health (CAH) in Q2 2026: 15,105 shares worth $3.59M. The stake represents ﹤0.01% of the portfolio and ranks #456 among its holdings. This is a return to the name: Loomis, Sayles & Company previously reported a position in CAH as recently as Q3 2025.
Loomis, Sayles & Company first reported a position in CAH in Q2 2013 and has held it in 30 quarters since. 1,495 funds tracked by Wall St. Rank hold CAH as of Q2 2026.
- Loomis, Sayles & Company held 15,105 shares of Cardinal Health worth $3.59M as of Q2 2026.
- Cardinal Health was a new Loomis, Sayles & Company position in Q2 2026.
- Cardinal Health made up ﹤0.01% of Loomis, Sayles & Company's portfolio in Q2 2026, its #456 holding.
- Loomis, Sayles & Company first reported a position in Cardinal Health in Q2 2013 and has held it in 30 quarters since.
- 1,495 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.
Based on Loomis, Sayles & Company's 13F filing for Q2 2026, filed 14 Aug 2026.